Review [inpr]
Series [qnco]
Lipoprotein (a) [aapp, bacs]
Age [orga]
Last [qlco]
Current [tmco]
Therapies [topp]
lowering [spco]
Lipoprotein (a) [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
human plasma [phsu]
Lipoprotein [aapp, bacs]
Unique [qlco]
Structural [spco]
Functional [ftcn]
Characteristics [qlco]
Lp(a) [aapp, bacs]
Assembly [acty]
Two [qnco]
Components [mnob]
central core [celc]
Apo-B [aapp, bacs]
Additional [ftcn]
Glycoprotein [aapp, carb]
Call [menp]
Apo-A [aapp, bacs]
Strong [qlco]
Association [menp]
Elevated [qlco]
Levels [qlco]
Lp(a) [aapp, bacs]
Increased [qnco]
Risk [qlco]
CVD, NOS [dsyn]
Interest [menp]
Therapeutic [topp]
Modulation [spco]
Lp(a) [aapp, bacs]
Level [qlco]
Increased [qnco]
Past [tmco]
Present [qnco]
Therapies [topp]
Aim [idcn]
To [qlco]
Lower [spco]
Lp(a) [aapp, bacs]
Level [qlco]
reviewed [inpr]
Agent [chvf]
degrees [qnco]
Success [socb]
Challenge [clna]
To [qlco]
Lp(a) [aapp, bacs]
lowering [spco]
???lead [elii, hops]
CARDIOVASCULAR [bdsy]
Benefit [qnco]
Patients [podg]
Elevated [qlco]
Lp(a) [aapp, bacs]
Level [qlco]
Highly [qlco]
Specific [qlco]
Potential [qlco]
Lp(a) [aapp, bacs]
lowering [spco]
strategies [menp]
Van [mnob]
[c] [qnco]
F- [inch, phsu]
M NOS [aapp, imft]
Van [mnob]
der [comd]
g% [qnco]
Current Therapy [topp]
lowering [spco]
Lipoprotein (a) [aapp, bacs]
